| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.5M | — | +13.9% |
| Cost of Revenue | $7.5M | — | +51.6% |
| Gross Profit | $2.0M | — | -41.0% |
| R&D Expense | $10.0M | — | +92.6% |
| SG&A Expense | $26.3M | — | +355.0% |
| Operating Income | -$33.6M | — | — |
| Pre-tax Income | -$30.3M | — | -405.6% |
| Income Tax | $0 | — | — |
| Net Income | -$30.3M | — | — |
| EPS (Basic) | -$0.26 | — | — |
| EPS (Diluted) | -$0.26 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $84.7M | +624.1% | — |
| Accounts Receivable | $6.9M | -28.1% | — |
| Inventory | $4.9M | +13.3% | — |
| Current Assets | $464.9M | — | — |
| Total Assets | $612.6M | +44.2% | — |
| Current Liabilities | $23.6M | -68.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.2M | — | — |
| Investing Cash Flow | -$433.1M | — | — |
| Financing Cash Flow | $525.2M | — | — |
| Total Liabilities | $27.4M | -65.3% | — |
| Stockholders' Equity | $585.3M | +854.0% | — |